Incannex Healthcare Inc. (IXHL)

NASDAQ: IXHL · Real-Time Price · USD

3.150

-0.080 (-2.48%)

Jul 16, 2026, 9:33 AM EDT - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
R&D of the Use of Psychedelic Medicine and Therapies	86.00K	12.00K		-	-	-
R&D of the Use of Psychedelic Medicine and Therapies Growth	616.67%	-		-	-	-
Medicinal Cannabis	-	-		539.05K	1.42M	417.62K
Medicinal Cannabis Growth	-	-		-62.11%	240.67%	-
Corporate	-	-		-	54.78K	-
Total	86.00K	12.00K		539.05K	1.48M	417.62K
Total Growth	616.67%	-		-63.52%	253.78%	38249.13%

Revenue by Geography

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Australia	86.00K	12.00K		539.05K	1.45M	417.62K
Australia Growth	616.67%	-		-62.84%	247.40%	38249.13%
Total	86.00K	12.00K		539.05K	1.45M	417.62K
Total Growth	616.67%	-		-62.84%	247.40%	38249.13%